DEREK KUES: Open Payments
NPI 1548718695 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,774 in 95 payments from 14 companies in 2025. Trend: 2023 $1,113 · 2024 $5,172 · 2025 $1,774
Food & beverage: $1,713Education: $61
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $494 |
| ABBVIE INC. | 34 | $441 |
| UCB, Inc. | 14 | $250 |
| Organon LLC | 5 | $162 |
| E.R. Squibb & Sons, L.L.C. | 4 | $158 |
| GENZYME CORPORATION | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Galderma Laboratories, L.P. | 2 | $44 |
| PFIZER INC. | 2 | $38 |
| Lilly USA, LLC | 1 | $25 |
Products named: TREMFYA, Bimzelx, RINVOQ, SKYRIZI, Sotyktu, VTAMA, DUPIXENT, CIBINQO.
Industry payments across OH — which companies pay providers there.
